Inscripta Completes $20M Expansion of Series C Financing, Increasing Total Round to $105.5M
Continued support of existing investors will fund commercialization efforts, product launch later this year Boulder, CO – April 4, 2019 – Inscripta, a leading gene-editing technology company, today announced that it has increased its previously announced Series C financing with an additional $20 million from existing investors. The new funding adds to the $85.5 million […]